News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Fisher & Paykel Healthcare.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Argenica jumps 20pc on Phase 2 update, Fisher&Paykel could lose $12m from recall
News
Small Cap Lunch Wrap: Weak ASX initiates ghost protocol ‘cos it’s almost the weekend
News
Market Highlights: Reddit rallies Wall Street as ASX opens all anxious
News
Traders’ Diary: Everything you need to get ready for the week ahead
News
ASX Large Caps: Big drop in CPI boosts rates-sensitive stocks; gold stocks also rally as bullion nears all-time high
News
ASX Small Cap Lunch Wrap: Oh what a CPI! Inflation elation as local markets jump on weak October prices
Health & Biotech
ASX Health Stocks: 4DX shares continue ascent after signing a deal with global player, Philips
Experts
SUNDAY ROAST: The stocks that lit a fire under our experts this week
Health & Biotech
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
Experts
Around the ASX in 7 companies at the Pinnacle of their game
News
ASX Large Caps: Mining stocks rise after MinRes’ results; cement maker Adbri dives 15pc on soft guidance
News
The Ethical Investor: Why Australian Ethical Investment dumped Lendlease, but loves Woolies
News
ASX Small Caps Lunch Wrap: Who else doesn’t fancy rat poisoned food today?
News
ASX Earnings Wrap: Fisher Paykel sees growth in China; Mad Paws’ revenue up 230pc
News
ASX Large Caps: Iron ore giants lift ASX as China’s property sector gets a timely boost
News
ASX Small Caps Lunch Wrap: Who else wants to bust up monopolies this morning?
News
